Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,886.24
(
1.02%
)
US TECH 100
24,753.20
(
1.27%
)
Dow Jones
48,218.25
(
0.63%
)
Brent Oil
95.22
(
-0.26%
)
Bitcoin
74,418.83
(
-0.11%
)
News Focus
News Focus

Replies to post #140841 on Anavex Life Sciences Corp (AVXL)

Replies to #140841 on Anavex Life Sciences Corp (AVXL)
icon url

Investor2014

02/12/18 10:18 PM

#140842 RE: georgesk #140841

The quest to promote the idea that A2-73 is not tolerable forcing low dose in the P2a Part B trial and beyond has no basis in fact.